Advertisement

Picture BIO Deutschland Dt Biotechnologietage DBT 2017 Hannover April 600x60px
Document › Details

Centogene AG. (6/1/14). "Presss Release: Centogene CEO Position Changed – Michael Schlenk Hands Over to Founder Prof Arndt Rolfs". Rostock.

Region Region Rostock
  Country Germany
Organisations Organisation Centogene AG
  Group Centogene (Group)
  Organisation 2 Curasan AG
Products Product molecular diagnostics
  Product 2 genetic test
  Index term 2 Centogene–OMERS (CA): investment, 201402 acquisition of Centogene’s Canadian business by LifeLabs
Persons Person Rolfs, Arndt (Univ Rostock Prof + Centogene 201406– CEO + Founder)
  Person 2 Schlenk, Michael (Curasan 201410– Executive Board Director before Centogene + ProBioGen)
     


After 3.5 years as Chief Executive Officer for Centogene and the successful completion of a 2-digit million deal with LifeLabs, the largest clinical-diagnostic laboratory in Canada, Michael Schlenk transfers the responsibilities as CEO to Prof. Arndt Rolfs MD.

Schlenk will continue to support the company as an active member of the supervisory board.

Over the last few years Centogene, an always profitable, completely venture capital free and rapidly growing company in the North of Germany, increased turnover and number of employees 4 fold. Today, Centogene is one of the leading molecular genetic diagnostic companies worldwide, specializing in rare diseases. With the broadest portfolio of over 2000 genetic tests, whole-exome and whole-genome platform as well as mass-spectrometry unit Centogene is a one-stop-shop for many of its customers from over 90 countries.

“With the capital from the Canadian partnership deal, we have the funds to further invest in technological expansion and automation. We will aggressively expand our Next Generation Sequencing leadership with over 150 specific and highly validated panels, the robots processing industry screening projects and the centerpiece of our business model, the CentoMD0174 Mutation Databse,” explains Michael Schlenk. “We are very fortunate that we could win the internationally reputated expert in genetics, our founder and visionary leader in genetics, Prof. Rolfs, to drive the technological expansion and raise Centogene to the next level as the new Chief Executive Officer.”

“Michael Schlenk will continue to support us with his network and strategic understanding as an active member of the supervisory board. We thank him for his substantial contributions in closing several very important business deals as a basis for further growth of Centogene,” said Prof. Arndt Rolfs, new CEO of Centogene AG.


About Centogene

Centogene is one of the leading laboratories focusing on genetic testing for rare hereditary disorders, offering mor than 2,000 routine genetic and biochemical tests. In addition the team performs the development of innovative biomarkers for lysosomal storage disorders and small molecules for the treatment of rare diseases. Centogene works with academic and industrial partners to co-develop cutting-edge diagnostic techniques and new orphan drugs.

For more information, please visit www.centogene.com


About Michael Schlenk

After over 20 years as senior executive, general manager and president in Pharma companies like Sandoz/Novartis and Abbott, Schlenk worked successfully in Biotech for over 10 years as CEO. As business angel, he invests in Life Science, but also IT companies and helps young organizations to develop their business model to stability and value creation.


About Arndt Rolfs

Arndt Rolfs, Professor for Neurology and Psychiatry at the University of Rostok, Germany and head of the Albrecht-Kossel-Institute for Neuroregeneration works for over 25 years in the field of clinical neurology and neurogenetic research. He is principal investigator of several international multicentre studies in the area of rare diseases. Rolfs has authored and contributed to more than 150 peer-reviewed publications, acts as a consultant for international biotech and industrial companies as well as for the EMA and FDA.

Furthermore, he was co-founder of biotech companies Arcensus AG and Genebanking AG.

   
Record changed: 2016-06-07

Advertisement

Picture BIO Deutschland Dt Biotechnologietage DBT 2017 Hannover April 600x60px

More documents for Centogene (Group)


To subscribe to our free, monthly newsletter for the life sciences in German-speaking Europe (DE, AT & CH), please send an e-mail to info@iito.de and simply fill the subject line with the word »LSG newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture Sacura e.tract software 2017 600x60px wpq




» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture AB Sciex Berliner LCMSMS Symposium 2017 Right 120x80px Picture VIB Conferences Revolutionizing Next Gen Sequencing 2017 120x180px Picture BIO Deutschland Dt Biotechnologietage DBT 2017 Hannover April 120x240px Picture EBD Group BIO-Europe Spring 2017 BES Barcelona Spain March 120x180px Picture Sacura e.tract software 2017 Barcelona 120x240px wpssy Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px